This inventor holds 4 USPTO granted patents. Top assignee: The Upjohn Co.. Active years: 1978.
Company Filing History:
Years Active: 1978
Title: James M. Koert: Innovator in Antibiotic Development
Introduction
James M. Koert is a notable inventor based in Kalamazoo, MI (US). He has made significant contributions to the field of antibiotic development, holding a total of 4 patents. His work focuses on the bioconversion of antibiotics, which has important implications for medical treatments.
Latest Patents
Koert's latest patents include a process for preparing 7-deoxysteffimycinol. This innovative method involves the bioconversion of the antibiotic steffimycinone to steffimycinol. Steffimycinol is known for its effectiveness against various microorganisms, including Bacillus subtilis, Mycobacterium avium, and Streptococcus pyogenes. The conversion of steffimycinol to 7-deoxysteffimycinol is achieved through a microaerophilic fermentation process using Aeromonas hydrophila. The resulting 7-deoxysteffimycinol is active against Sarcina lutea, Bacillus cereus, and B. subtilis, making these antibiotics valuable for inhibiting the growth of harmful microorganisms in diverse environments.
Career Highlights
Koert is associated with The Upjohn Company, where he has been instrumental in advancing antibiotic research. His innovative approaches have contributed to the development of effective treatments for bacterial infections. His expertise in bioconversion processes has positioned him as a key figure in the field.
Collaborations
Some of his notable coworkers include Paul F. Wiley and Vincent P. Marshall. Their collaborative efforts have further enhanced the research and development of antibiotics.
Conclusion
James M. Koert's work in antibiotic development showcases his commitment to advancing medical science. His innovative patents and collaborations highlight the importance of research in combating bacterial infections.